Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line

Blood

Volumn 88, Issue 9, 1996, Pages 3299-3305

  Pinto, Antonio ^a   Aldinucci, Donatella ^b   Gloghini, Annunziata ^b   Zagonel, Vittorina ^b   Degan, Massimo ^b   Improta, Salvatore ^b   Juzbasic, Senka ^b   Todesco, Michela ^b   Perin, Vilma ^b   Gattei, Valter ^b   Herrmann, Friedhelm ^b   Gruss, Hans Jürgen ^b   Carbone, Antonino ^b  

^a Department of Medical Oncology   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; MESSENGER RNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EOSINOPHIL; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; LYMPHOMA CELL LINE; PRIORITY JOURNAL; REED STERNBERG CELL;

EID: 10344244536     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3299.bloodjournal8893299     Document Type: Article

References (51)

1. Kaplan HS: Hodgkin's Disease (ed 2). Cambridge, MA, Harvard University Press, 1980
2. Kadin ME: Pathology of Hodgkin's disease. Curr Opin Oncol 6:456, 1994
3. Dreschfeld J: Clinical lecture on acute Hodgkin's disease. Br Med J 1:893, 1892
4. Major RH, Leger LH: Marked eosinophilia in Hodgkin's disease. JAMA 112:2601, 1939
5. Samoszuk MK, Ramzi E: IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease. Leuk Lymphoma 9:315, 1993
6. Fuggle WJ, Crocker J, Smith PJ: A quantitative study of eosinophil polymorphs in Hodgkin's disease. J Clin Pathol 37:267, 1984
7. Samoszuk MK, Sholly S, Epstein AL: Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease. Lab Invest 56:394, 1987
8. Butterfield JH, Kephart GM, Banks PM, Gleich GJ: Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease. Blood 68:1250, 1986
9. Sanderson CJ: Interleukin-5, eosinophils and disease. Blood 79:3101, 1992
10. Wardlaw AJ, Moqbel R, Kay AB: Eosinophils: Biology and role in disease. Adv Immunol 60:151, 1995
11. Gruss H-J, Hermann F, Drexler HG: Hodgkin's disease: A cytokine producing tumor. Crit Rev Oncog 5:23, 1994
12. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 9:1, 1993
13. Haluska FG, Brufsky AM, Cannellos GP: The cellular biology of Reed-Sternberg cell. Blood 84:1005, 1994
14. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 13:501, 1992
15. Samoszuk MK, Nansen L: Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13, 1990
16. Merz H, Fliedner A, Orscheschek K, Binder Th, Sebald W, Muller-Hermelink HK, Feller AC: Cytokine expression in T-cell lymphomas and Hodgkin's disease. Am J Pathol 139:1173, 1991
17. Samoszuk M: IgE in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 76:1518, 1992
18. Gruss H-J, Dower SK: TNF ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85:3378, 1995
19. Poppema S: The biology of Hodgkin's disease. Ann Oncol 3:S5, 1992 (suppl 4)
20. Carbone A, Gloghini A, Gattei V, Aldinucci D, Degan M, De Paoli P, Zagonel V, Pinto A: Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 85:780, 1995
21. Yang Y-C: Human interleukin-9: A new cytokine in hematopoiesis. Leuk Lymphoma 8:441, 1992
22. Dürkop H, Latza U, Hummel M, Eithelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992
23. Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1, 1995
24. Smith CA, Gruss H-J, Davis T, Anderson D, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din SW, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
25. Gruss H-J, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83:2045, 1994
26. Gruss H-J, Da Silva N, Hu Z-B, Uphoff CC, Goodwin RG, Drexler HG: Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Leukemia 8:2083, 1994
27. Gruss H-J, Ulrich D, Braddy S, Armitage R, Dower SK: Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur J Immunol 25:2083, 1995
28. Carbone A, Gloghini A, Zagonel V, Aldinucci D, Gattei V, Degan M, Improta S, Sorio R, Monfardini S, Pinto A: The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 86:4617, 1995
29. Brattig NW, Medina-De la Garza CE, Tischendorf FW: Comparative study of eosinophils purification on nycodenz, metrizamide and percoll density gradients. Eur J Haematol 39:148, 1987
30. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS, Thomson RA: Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 122:97, 1989
31. Gruss H-J, Pinto A, Gloghini A, Wright B, Boiani N, Aldinucci D, Gattei V, Zagonel V, Smith GA, Kadin ME, von Schilling C, Goodwin RG, Herrmann F, Carbone A: CD30 ligand expression in normal, reactive and Hodgkin's disease-involved lymph nodes. Am J Pathol 149:469, 1996
32. Th'ng KH, Garewal G, Kearney L, Rassool F, Melo JV, White H, Catowsky D, Foroni L, Luzzatto L, Goldman JM: Establishment and characterization of three new malignant lymphoid cell lines. Int J Cancer 39:89, 1987
33. Owen WF, Rothenberg ME, Petersen J, Weller PF, Silberstein D, Sheffer AL, Stevens RL, Soberman R, Austen F: Interleukin-5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:343, 1989
34. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA: Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 148:2390, 1992
35. Endo M, Usuki K, Kitazume K, Iwabe K, Okuyama Y, Urabe A: Hypereosinophilic syndrome in Hodgkin's disease with increased granulocyte-macrophage colony-stimulating factor. Ann Hematol 71:313, 1995
36. Butterfield JH, Leiferman KM, Abrams J, Silver JE, Bower J, Gonchoroff N, Gleick GJ: Elevated serurn levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79:688, 1992
37. Koike T, Enokihara H, Arimura H, Ninomya H, Yamashiro K, Tsuruoka N, Tsujimoto M, Aoyagi M, Watanabe K, Nakamura Y, Saitou K, Furosawa S, Shishido H: Serum concentrations of IL-5, GM-CSF, and IL-3 and the production by lymphocytes in various eosinophilia. Am J Hematol 50:98, 1995
38. Kaplan D. Autocrine secretion and the physiological concentration of cytokines. Immunol Today 17:303, 1996
39. Druilhe A, Cai Z, Hailé S, Chouaib S, Petrolani M: Fasmediated apoptosis in cultured human eosinophils. Blood 87:2822, 1996
40. Gauchat JF, Henchoz S, Fattah D, Mazzei G, Aubry JP, Jomotte T, Dash L, Page K, Solari R, Aldebert D, Capron M, Dahinden C, Bonnefoy J-Y: CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 25:863, 1995
41. Gruss H-J, Hirschstein D, Wright B, Ulrich D, Caligiuri MA, Strockbine L, Armitage RJ, Dower SK: Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 84:2305, 1994
42. Elliss TM, Simms PE, Slivink DJ, Jack H-M, Fisher RI: CD30 is a signal-transducing molecule that defines a subset of human activated CD45R0+ T cells. J Immunol 151:2380, 1993
43. Alzona M, Jäck H-M, Fisher R, Ellis TM: CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J Immunol 153:2867, 1994
44. Del Prete GF, De Carli M, Almerigogna F, Daniel CK, D'elios MM, Zancuoghi G, Pizzolo G, Romagnani S: Preferential expression of CD30 by human CD4+ T-cells producing Th2-type cytokines. FASEB J 9:81, 1995
45. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138, 1996
46. Poppema S: The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol 135:351, 1989
47. Vaughan Hudson B, Linch DC, Macintyre EA, Bennett MH, Maclennan KA, Vaughan Hudson G, Jellife AM: Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI report no 31). J Clin Pathol 40:247, 1987
48. Desenne JJ, Acquatella G, Stern R, Muller A, Sanchez M, Somoza R: Blood eosinophilia in Hodgkin's disease. Cancer 69:1428, 1992
49. Toth J, Dvorak O, Sugar J: Eosinophil predominance in Hodgkin's disease. Z Krebsforsch 89:107, 1977
50. Enblad G, Sundstrom C, and Glimelius B: Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 11:187, 1993
51. Poppema S: Lymphocyte predominance Hodgkin's disease. Semin Diag Pathol 9:257, 1992